Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatology with Rhythm

Rainer H. Straub, MD, and Maurizio Cutolo, MD  |  Issue: February 2008  |  February 1, 2008

From these data, it is evident that the amplitude of the curve of cytokine production is higher and the curve is broadened in RA as compared to controls. In healthy subjects, serum levels of IL-6 usually decrease by 9 a.m. whereas, in RA patients, these levels can remain elevated until 11 a.m. The increased amplitude and the broadened curve in the morning hours are important for the morning symptoms. Interestingly, a circadian rhythm exists for the production of immunoglobulins in RA, as has been demonstrated for IgA–rheumatoid factor (peak at 8 a.m.).3 Furthermore, circulating immune complexes demonstrate a circadian rhythmicity in RA with a peak between 6 and 9 a.m.4 These findings demonstrate that two other important disease-relevant parameters display an elevation in the early morning hours in patients with RA.

FIGURE 2: Targets of the SCN are depicted. The targets include sleeping, arousal, and feeding centers; other nuclei in the hypothalamus and the pineal gland; and higher centers of the sympathetic nervous system (SNS). The interaction of the SCN neurons with these areas leads to the known circadian rhythmicity of many different neuroendocrine systems that transmit their signals by hormones and neurotransmitters to the periphery. Abbreviations: ACTH, adrenocorticotropic hormone; ADH, anti-diuretic hormone; CRH, corticotrophin-releasing hormone; FSH, follicle-stimulating hormone; GH, growth hormone; GHRH, GH-releasing hormone; GnRH, go-nadotropin–releasing hormone; LH, luteinizing hormone; TRH, thyrotropin releasing hormone; TSH, thyrotropin.
click for large version
FIGURE 2: Targets of the SCN are depicted. The targets include sleeping, arousal, and feeding centers; other nuclei in the hypothalamus and the pineal gland; and higher centers of the sympathetic nervous system (SNS). The interaction of the SCN neurons with these areas leads to the known circadian rhythmicity of many different neuroendocrine systems that transmit their signals by hormones and neurotransmitters to the periphery. Abbreviations: ACTH, adrenocorticotropic hormone; ADH, anti-diuretic hormone; CRH, corticotrophin-releasing hormone; FSH, follicle-stimulating hormone; GH, growth hormone; GHRH, GH-releasing hormone; GnRH, go-nadotropin–releasing hormone; LH, luteinizing hormone; TRH, thyrotropin releasing hormone; TSH, thyrotropin.

In view of these observations, the key question is, What is driving the circadian oscillation of serum levels of cytokines?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Circadian Rhythm of Cortisol

The adrenal hormone cortisol is an endogenous steroid with anti-inflammatory actions. In the 1950s and 1960s, shortly after the discovery of cortisol, the circadian rhythm of this hormone was described. The cycle of the hypothalamic-pituitary-adrenal (HPA) axis has a maximum in the early morning hours at 8 a.m. and a nadir at midnight (see Figure 3, p. 16). Detailed analyses of the circadian curves of cytokines and cortisol have revealed a lag time between the cortisol rise in comparison to the increase of cytokine of approximately 60–120 min.5 From this study and a recent analysis of several independent investigations, it appears that morning cytokines can drive the increase of cortisol.2

Interestingly, the cortisol rhythm in healthy subjects does not differ from that of patients with RA when disease activity is relatively low to moderate. This similarity pertains to the period, the amplitude, and the time point of the minimum and peak of the cycle. Studies have shown, however, that this rhythm can be disturbed in patients with RA when disease activity is high, leading to a flattening of the hormone curve. Nevertheless, the serum levels of cortisol are similar in healthy subjects compared to patients with RA.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:circadian rhythmCytokinesDiagnostic CriteriaPathogenesisrheumatologistTreatment

Related Articles

    Rheuminations: Circadian Rhythms May Play Role in Inflammatory Disease

    May 1, 2013

    Research into how the timing of light and dark exposures control our lives could provide clues to why some people have immunologic disorders

    Chronotherapy with Glucorticoids in Rheumatoid Arthritis

    January 17, 2011

    Time is of the essence in balancing risks and benefits

    How Energy Shifts Lead to Systemic Illness

    July 12, 2011

    The impact of adaptive energy programs on the manifestations of chronic inflammatory disease

    What Fat Does to Arthritis

    August 1, 2011

    The role of adipokines in the pathogenesis of rheumatic diseases

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences